DexCom (DXCM) Financials: Revenue & Earnings

DXCM$79.41-5.05 -5.98%

$29.62B

Market Cap

29.89

P/E

26.97

Forward P/E

62

Score

AI Analysis

Snapshot

DexCom looks like a quality compounder first — Quality 80/100 and an overall 62/100. Under the hood: P/E 34.2, about 60% below its own multi-year median, plus revenue compounding ~17% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

38
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

69
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

80
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

DexCom, Inc. (DXCM) last printed $79.41. Equity value is $29.62B. Trailing earnings multiple 29.89. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$573.3M$718.5M$1.03B$1.48B$1.93B$2.45B$2.91B$3.62B$4.03B$4.66B

About

DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.

DexCom (DXCM) Financials: Revenue & Earnings

DXCM price $79.41 -5.05 -5.98%

Ticker
DXCM
Price
$79.41
Change
-5.05 -5.98%
Market cap ?
$29.62B
P/E ?
29.89
Forward P/E ?
26.97
Dividend yield ?
0.00%
Beta ?
1.45
Sector
Healthcare
Industry
Medical - Devices
Stocklytics score
62
Value
38
Quality
80
Growth
69

Stocklytics score rationale: value 38, quality 80, growth 69.

AI Score 75. DexCom, Inc. has a solid market capitalization of approximately $32.99 billion and a strong gross profit margin of 63.4%, indicating effective cost management

Fair value

DXCM fair value $67.18. Price $79.41. Price is 18% above fair value.

Above fair value, but less expensive than usual. A smaller premium than on 80% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price.

Fair value blends a 10-year DCF and an earnings multiple: the average of the DCF value and an earnings value from next-twelve-months EPS times 30.0, a blend of the Medical - Devices median (24.9) and the stock's own 10-year median (86.2). How we calculate it →

Compare DXCM

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-02-11—0.71—1.38B
2026-10-290.730.681.34B1.33B
2026-07-300.700.611.31B1.29B
2026-04-300.560.471.19B1.17B
2026-02-120.680.651.26B1.25B
2025-10-300.610.581.21B1.18B
2025-07-300.480.441.16B1.12B
2025-05-010.320.331.04B1.02B
2025-02-130.450.481.11B1.11B
2024-10-240.450.44994.20M990.44M
2024-07-250.430.391.00B1.04B
2024-04-250.320.27921.00M909.93M
2024-02-080.500.431.03B1.01B
2023-10-260.500.34975.00M939.24M
2023-07-270.340.23871.30M841.62M
2023-04-270.170.15741.50M720.74M
2023-02-090.340.26815.20M810.10M
2022-10-270.280.24769.60M751.80M
2022-07-280.170.17696.20M697.50M
2022-04-280.080.13628.80M623.87M
2022-02-100.170.22698.20M697.47M
2021-10-280.220.16650.20M617.69M
2021-07-290.190.11595.10M513.79M
2021-04-290.080.08505.00M484.55M
2021-02-110.230.23568.90M575.08M
2020-10-270.240.16500.90M346.44M
2020-07-280.200.08451.80M431.31M
2020-04-280.110.04405.10M128.90M
2020-02-130.290.18462.80M297.80M
2019-11-060.160.05396.30M121.94M
2019-07-310.020.00336.40M42.05M
2019-05-01-0.01-0.01280.50M897.60M
2019-02-210.140.04338.00M106.41M
2018-11-060.040.01266.70M156.88M
2018-08-01-0.03-0.05242.50M436.50M
2018-05-02-0.08-0.08184.40M190.16M
2018-02-270.030.01221.00M66.30M
2017-11-01-0.01-0.01184.60M738.40M
2017-08-01-0.04-0.06170.60M223.91M
2017-05-02-0.12-0.14142.30M145.20M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-30Ashley Euan A.Sell2.39K——
2026-10-27Stern SadieSell2.56K$78.62201.66K
2026-10-15Brown Michael JonSell1.70K$85.48145.32K
2026-09-28Stern SadieSell2.56K$86.15220.97K
2026-09-15AUGUSTINOS NICHOLASSell6.54K$84.04549.54K
2026-09-15Brown Michael JonSell1.70K$84.04142.87K
2026-09-14AUGUSTINOS NICHOLASSell1.55K$84.02130.23K
2026-09-10Sylvain Jereme MSell3.64K$83.27302.94K
2026-09-10Boehnlein Glenn SBuy5.84K——
2026-09-10Boehnlein Glenn SOther0——
2026-08-27Stern SadieSell2.56K$88.37226.67K
2026-08-22Leach Jacob StevenSell1.45K$92.34133.99K
2026-08-22Sylvain Jereme MSell1.45K$92.34133.99K
2026-08-22Brown Michael JonSell1.45K$92.34133.99K
2026-08-22Stern SadieSell1.45K$92.34133.99K
2026-08-20SAYER KEVIN RSell19.31K$89.711.73M
2026-08-20SAYER KEVIN RSell7.35K$90.78667.33K
2026-08-20SAYER KEVIN RSell97$91.418.87K
2026-08-14Brown Michael JonSell1.70K$91.93156.28K
2026-08-12AUGUSTINOS NICHOLASSell1.07K——
2026-08-12Heller Bridgette PSell1.01K$88.2989.35K
2026-08-03FOLETTA MARK GSell2.00K$85.32170.64K
2026-07-31FOLETTA MARK GSell2.00K$80.00160.00K
2026-07-20SAYER KEVIN RSell26.76K$76.322.04M
2026-07-15Brown Michael JonSell1.70K$74.42126.51K
2026-07-06SAYER KEVIN RSell26.76K$72.001.93M
2026-06-15Brown Michael JonSell1.70K$75.55128.44K
2026-06-15FOLETTA MARK GSell3.80K$74.10281.65K
2026-06-15FOLETTA MARK GSell199$74.8214.89K
2026-06-04Coleman JonSell4.91K$74.13364.05K
2026-06-03Coleman JonSell4.91K$73.00358.58K
2026-05-28ALTMAN STEVEN RBuy5.57K——
2026-05-28Malady KyleBuy5.58K——
2026-05-28AUGUSTINOS NICHOLASBuy5.58K——
2026-05-28FOLETTA MARK GBuy6.33K——
2026-05-28Heller Bridgette PBuy5.58K——
2026-05-28Osterloh Albert Frederick IVBuy1.63K——
2026-05-28Driscoll RimmaBuy5.61K——
2026-05-28Ashley Euan A.Buy5.57K——
2026-05-28Collins Richard AlexanderBuy5.61K——
2026-05-28GALA RENEE DBuy5.61K——
2026-05-22Leach Jacob StevenSell1.45K$71.90104.33K
2026-05-22Brown Michael JonSell1.45K$71.90104.33K
2026-05-22Sylvain Jereme MSell1.45K$71.90104.33K
2026-05-22Stern SadieSell1.45K$71.90104.33K
2026-05-22Coleman JonSell7.36K$71.90529.33K
2026-05-21SAYER KEVIN RSell26.76K$72.001.93M
2026-05-15Brown Michael JonSell1.70K$59.91101.85K
2026-05-12Heller Bridgette PSell1.01K$60.0160.73K
2026-05-08AUGUSTINOS NICHOLASBuy5.05K——
2026-05-08AUGUSTINOS NICHOLASSell5.05K——
2026-05-08Collins Richard AlexanderBuy5.07K——
2026-05-08Collins Richard AlexanderSell5.07K——
2026-05-08FOLETTA MARK GBuy5.73K——
2026-05-08FOLETTA MARK GSell5.73K——
2026-05-08ALTMAN STEVEN RBuy5.04K——
2026-05-08ALTMAN STEVEN RSell5.04K——
2026-04-15Brown Michael JonSell1.70K$63.04107.17K
2026-03-16Brown Michael JonSell1.70K$64.85110.24K
2026-03-08SAYER KEVIN RBuy32.75K——
2026-03-08SAYER KEVIN RSell32.50K$68.102.21M
2026-03-08Sylvain Jereme MBuy48.77K——
2026-03-08Sylvain Jereme MSell18.95K$68.101.29M
2026-03-08Brown Michael JonBuy39.02K——
2026-03-08Brown Michael JonSell23.32K$68.101.59M
2026-03-08Stern SadieBuy39.02K——
2026-03-08Stern SadieSell17.20K$68.101.17M
2026-03-08Leach Jacob StevenBuy104.52K——
2026-03-08Leach Jacob StevenSell19.76K$68.101.35M
2026-03-08Coleman JonBuy43.90K——
2026-02-26Osterloh Albert Frederick IVBuy7.06K——
2026-02-26Osterloh Albert Frederick IVOther0——
2026-02-12Heller Bridgette PSell1.01K$68.0168.83K
2026-01-29Leach Jacob StevenBuy8.31K——
2026-01-29Leach Jacob StevenSell3.06K$73.36224.33K
2026-01-29Stern SadieBuy7.12K——
2026-01-29Stern SadieSell2.66K$73.36194.84K
2026-01-29Sylvain Jereme MBuy7.12K——
2026-01-29Sylvain Jereme MSell2.65K$73.36194.55K
2026-01-29Brown Michael JonBuy7.12K——
2026-01-29Brown Michael JonSell2.65K$73.36194.62K
2026-01-29SAYER KEVIN RBuy71.22K——
2026-01-29SAYER KEVIN RSell34.26K$73.362.51M
2025-11-14Collins Richard AlexanderSell2.91K$59.05171.60K
2025-11-12Heller Bridgette PSell1.01K$58.0758.77K
2025-11-10Leach Jacob StevenBuy2.50K$55.43138.56K
2025-11-10Leach Jacob StevenBuy15.70K$54.98863.14K
2025-11-10Collins Richard AlexanderSell3.95K$55.17217.81K
2025-10-24Ashley Euan A.Buy7.17K——
2025-10-24Ashley Euan A.Other0——
2025-09-05Malady KyleSell667$80.8653.93K
2025-09-04Stern SadieSell1.47K$80.00117.28K
2025-09-02Sylvain Jereme MSell4.82K$74.17357.80K
2025-08-15Brown Michael JonSell500$80.2940.15K
2025-08-15FOLETTA MARK GSell2.56K$81.02207.00K
2025-08-15FOLETTA MARK GSell195$81.5415.90K
2025-07-28Stern SadieSell1.47K$88.99130.46K
2025-07-15FOLETTA MARK GSell2.74K$85.17233.53K
2025-07-15FOLETTA MARK GSell8$86.03688
2025-07-15Brown Michael JonSell500$86.0343.02K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 1.03K, holders +14 vs prior quarter. Ownership 101.12%.

HolderSharesChangeChange %Value
BLACKROCK, INC.38.24M-720.23K-1.85%2.58B
VANGUARD CAPITAL MANAGEMENT LLC25.21M188.79K+0.75%1.70B
VANGUARD PORTFOLIO MANAGEMENT LLC19.66M436.59K+2.27%1.32B
STATE STREET CORP18.38M445.96K+2.49%1.24B
INVESCO LTD.15.29M7.21M+89.27%1.03B
BAILLIE GIFFORD & CO14.80M-797.93K-5.12%996.89M
GEODE CAPITAL MANAGEMENT, LLC12.43M79.88K+0.65%834.17M
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC11.26M1.52M+15.55%758.49M
ALLIANCEBERNSTEIN L.P.11.69M-1.23M-9.52%734.35M
WELLINGTON MANAGEMENT GROUP LLP8.53M-798.77K-8.56%574.33M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP6.87M4.33M+170.06%462.91M
NORGES BANK6.87M6.87MNew462.57M
UBS GROUP AG6.07M1.72M+39.44%408.53M
AMUNDI5.60M-729.07K-11.51%377.40M
MORGAN STANLEY5.16M114.24K+2.27%347.28M
AMERIPRISE FINANCIAL INC4.82M579.99K+13.68%324.68M
CASTLE HOOK PARTNERS LP3.87M3.07M+382.68%260.67M
GOLDMAN SACHS GROUP INC3.76M714.98K+23.49%253.14M
FRANKLIN TEMPLETON INC3.60M988.46K+37.91%242.18M
MASSACHUSETTS FINANCIAL SERVICES CO /MA/3.56M1.63M+84.06%240.92M
CIBC BANCORP USA INC.3.45M-762.40K-18.08%232.97M
JPMORGAN CHASE & CO3.33M-2.67M-44.58%232.69M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.3.44M3.44MNew231.63M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC3.44M263.87K+8.31%231.63M
NORTHERN TRUST CORP3.30M-129.88K-3.79%221.93M

Insights · Forecast · Financials · Learn

Stocklytics home · Screener